Karpus Investment Management’s AbbVie ABBV Stock Holding History

Karpus Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$228K	Hold	1,050	–	–	0.01%	222
2025 Q4	$240K	Hold	1,050	–	–	0.01%	208
2025 Q3	$243K	Buy	+1,050	New	+$214K	0.01%	198
2025 Q2	–	Sell	-1,050	Closed	-$220K	–	200
2025 Q1	$220K	Buy	+1,050	New	+$204K	0.01%	197
2024 Q4	–	Sell	-1,050	Closed	-$207K	–	206
2024 Q3	$207K	Buy	+1,050	New	+$196K	0.01%	213

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Karpus Investment Management's ABBV Position: Q1 2026 in Review

Karpus Investment Management held its AbbVie (ABBV) position steady in Q1 2026 at 1,050 shares worth $228K. The position accounts for 0.01% of the portfolio, ranked #222.

Karpus Investment Management first reported a position in ABBV in Q3 2024 and has held it in 5 quarters since. The position peaked at $243K in Q3 2025. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Karpus Investment Management held 1,050 shares of AbbVie worth $228K as of Q1 2026.
Karpus Investment Management left its AbbVie share count unchanged in Q1 2026.
AbbVie made up 0.01% of Karpus Investment Management's portfolio in Q1 2026, its #222 holding.
Karpus Investment Management first reported a position in AbbVie in Q3 2024 and has held it in 5 quarters since.
Karpus Investment Management's AbbVie position peaked at $243K in Q3 2025.
4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Karpus Investment Management's 13F filing for Q1 2026, filed 14 May 2026.